Neotribe Ventures - Neotribe Ventures

Sign in Subscribe

Neotribe Ventures

Investing in breakthrough technologies that stretch the imagination.

AI-First Medical Technology Will Transform Healthcare and Save Lives

AI-First Medical Technology Will Transform Healthcare and Save Lives

John Carroll, co-founder and co-CEO of Vexev, shares how AI-first, point-of-care medical imaging and autonomous robotics can enable earlier detection of vascular failure in dialysis patients, helping prevent life-threatening complications before they escalate.

Commerce 3.0: The Next Wave of Transformative Commerce

Commerce 3.0: The Next Wave of Transformative Commerce

Node CEO Rohan Mahadevan explains how Commerce 3.0 replaces passwords, spam, and guest logins with a consumer-centric model powered by AI, device ubiquity, and cryptography—making every device a secure commerce assistant.

From Intelligence to Action: The 3 Stages of AI Transformation in Marketing

Marketing Featured

From Intelligence to Action: The 3 Stages of AI Transformation in Marketing

Despite a decade of martech innovation, end-to-end marketing intelligence has remained too complex and expensive to achieve at scale. RevSure Founder & CEO Deepinder Singh Dhingra explains how agentic AI is finally solving this trillion-dollar problem.

The Back Office Paradox: How the Most Risk-Averse Teams Became Agentic AI's Earliest Adopters

The Back Office Paradox: How the Most Risk-Averse Teams Became Agentic AI's Earliest Adopters

Founder and CEO of Auditoria, Rohit Gupta, reveals how agentic AI is revolutionizing traditionally conservative back office functions by delivering the strict accuracy and fiscal responsibility that CFOs value.

Arcade.dev: Making AI Agents Work—Securely

Announcement Featured

Arcade.dev: Making AI Agents Work—Securely

We're excited to double down on our support for Alex Salazar and Sam Partee as they announce their Seed round for Arcade.dev, to provide secure authenticated connectors for AI Apps.

The Power of One: Using Single Molecule Sensitivity Diagnostics to Fight Cancer

Portfolio Featured

The Power of One: Using Single Molecule Sensitivity Diagnostics to Fight Cancer

BillionToOne's Oguzhan Atay explores how advances in liquid biopsy technology offer single-molecule sensitivity to detect and quantify cancer DNA with unprecedented accuracy, improving therapy selection, treatment monitoring, and potentially enabling early-stage cancer diagnosis in the near future.